ClinicalTrials.govpublic full text
ALXN2350 in Adult Participants With BAG3-Associated Dilated Cardiomyopathy
bag3 mutation associated dilated cardiomyopathy, alxn2350, gene therapy, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 908043
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.